Otter Creek Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,801
| Closed | -$2.89M | – | 52 |
|
|
2025
Q1 | $2.89M | Sell |
5,801
-3,100
| -35% | -$1.68M | 1.73% | 29 |
|
|
2024
Q4 | $4.63M | Buy |
+8,901
| New | +$4.89M | 3.19% | 21 |
|
|
2024
Q3 | – | Sell |
-2,400
| Closed | -$1.33M | – | 39 |
|
|
2024
Q2 | $1.33M | Sell |
2,400
-5,000
| -68% | -$2.86M | 0.86% | 37 |
|
|
2024
Q1 | $4.3M | Sell |
7,400
-300
| -4% | -$168K | 2.55% | 17 |
|
|
2023
Q4 | $4.09M | Buy |
7,700
+4,100
| +114% | +$1.98M | 2.43% | 8 |
|
|
2023
Q3 | $1.82M | Sell |
3,600
-5,500
| -60% | -$2.93M | 1.4% | 29 |
|
|
2023
Q2 | $4.75M | Buy |
9,100
+2,500
| +38% | +$1.35M | 2.78% | 12 |
|
|
2023
Q1 | $3.8M | Buy |
+6,600
| New | +$3.72M | 2.73% | 7 |
|
|
2022
Q4 | – | Sell |
-7,510
| Closed | -$3.81M | – | 55 |
|
|
2022
Q3 | $3.81M | Buy |
+7,510
| New | +$4.2M | 3.1% | 14 |
|
|
2022
Q2 | – | Sell |
-3,909
| Closed | -$2.31M | – | 59 |
|
|
2022
Q1 | $2.31M | Buy |
+3,909
| New | +$2.25M | 0.93% | 43 |
|
|
2021
Q1 | – | Sell |
-5,072
| Closed | -$2.36M | – | 59 |
|
|
2020
Q4 | $2.36M | Sell |
5,072
-3,655
| -42% | -$1.71M | 1.88% | 23 |
|
|
2020
Q3 | $3.85M | Sell |
8,727
-1,958
| -18% | -$809K | 3.42% | 11 |
|
|
2020
Q2 | $3.87M | Sell |
10,685
-1,675
| -14% | -$561K | 3.07% | 12 |
|
|
2020
Q1 | $3.5M | Sell |
12,360
-500
| -4% | -$158K | 3.79% | 7 |
|
|
2019
Q4 | $4.18M | Sell |
12,860
-749
| -6% | -$227K | 2.07% | 16 |
|
|
2019
Q3 | $3.96M | Sell |
13,609
-3,290
| -19% | -$942K | 2.2% | 20 |
|
|
2019
Q2 | $4.96M | Hold |
16,899
| – | – | 1.92% | 18 |
|
|
2019
Q1 | $4.63M | Sell |
16,899
-1,250
| -7% | -$311K | 1.41% | 25 |
|
|
2018
Q4 | $4.06M | Sell |
18,149
-2,093
| -10% | -$491K | 1.45% | 26 |
|
|
2018
Q3 | $4.94M | Sell |
20,242
-2,649
| -12% | -$609K | 1.23% | 36 |
|
|
2018
Q2 | $4.74M | Buy |
22,891
+2,471
| +12% | +$525K | 1% | 44 |
|
|
2018
Q1 | $4.21M | Sell |
20,420
-12,607
| -38% | -$2.65M | 0.89% | 44 |
|
|
2017
Q4 | $6.27M | Sell |
33,027
-17,415
| -35% | -$3.34M | 0.9% | 52 |
|
|
2017
Q3 | $9.54M | Sell |
50,442
-4,637
| -8% | -$840K | 1.23% | 43 |
|
|
2017
Q2 | $9.61M | Sell |
55,079
-11,518
| -17% | -$1.93M | 1.37% | 34 |
|
|
2017
Q1 | $10.2M | Buy |
66,597
+3,318
| +5% | +$507K | 1.51% | 28 |
|
|
2016
Q4 | $8.93M | Sell |
63,279
-15,291
| -19% | -$2.25M | 1.04% | 42 |
|
|
2016
Q3 | $12.5M | Buy |
78,570
+8,873
| +13% | +$1.37M | 1.87% | 19 |
|
|
2016
Q2 | $10.3M | Sell |
69,697
-2,500
| -3% | -$369K | 1.86% | 16 |
|
|
2016
Q1 | $10.2M | Buy |
72,197
+30,247
| +72% | +$4.05M | 1.87% | 15 |
|
|
2015
Q4 | $5.95M | Buy |
+41,950
| New | +$5.6M | 1.74% | 20 |
|
Other funds holding TMO
Otter Creek Advisors's TMO Position: Q2 2025 in Review
Otter Creek Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 5,801 shares — an estimated $2.89M sold.
Otter Creek Advisors first reported a position in TMO in Q4 2015 and held it in 31 quarters. The position peaked at $12.5M in Q3 2016. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Otter Creek Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
- Otter Creek Advisors sold 5,801 Thermo Fisher Scientific shares in Q2 2025, an estimated $2.89M.
- Otter Creek Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and held it in 31 quarters.
- Otter Creek Advisors's Thermo Fisher Scientific position peaked at $12.5M in Q3 2016.
- 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Otter Creek Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.